764648 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
340 A phase Ib study of the safety and tolerability of pixatimod plus nivolumab in subjects with advanced solid tumors with an expansion cohort in metastatic pancreatic adenocarcinoma (mPDAC) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.340 |
Lemech Charlotte, Dredge Keith, Bampton Darryn, Hammond Edward, Stanley Amanda, Leveque-ElMouttie Lucie, Chojnowski Grace, Haydon Andrew, Pavlakis Nick, Burge Matthew, Brown Michael, Goldstein David |
764647 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
339 Immune profiling to investigate improved survival in patients with metastatic triple-negative breast cancer receiving trilaciclib prior to chemotherapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.339 |
Stevens Aaron, O’Shaughnessy Joyce, Cao Subing, Sorrentino Jessica, Horton Janet, Yi John, Tan Antoinette |
764646 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
72 Spatial whole transcriptome profiling of the tumor microenvironment in prostate carcinomas |
2021-11-01 |
10.1136/jitc-2021-sitc2021.072 |
Anaparthy Naishitha, Giangarra Valeria, Taylor Sarah, Turkekul Mesruh, Williams Stephen, Mielinis Paulius, Gallant Caroline |
764645 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
869 Locally administered immunotherapy self-delivering RNAi PH-762 results in abscopal clearance of untreated distal tumors, suggesting systemic immune response, in a murine hepatocarcinoma model |
2021-11-01 |
10.1136/jitc-2021-sitc2021.869 |
Cuiffo Benjamin, Maxwell Melissa, Yan Dingxue, Rivest Brianna, Cardia James, Fricker Simon |
764644 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
868 Overall survival on tebentafusp in metastatic uveal melanoma (mUM) across the range of tumor gp100 expression levels |
2021-11-01 |
10.1136/jitc-2021-sitc2021.868 |
Leach Emma, Stanhope Sarah, Naidoo Revashnee, Abdullah Shaad, Collins Laura, Ranade Koustubh |
764643 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
867 TriTAC-XR is an extended-release T cell engager platform designed to minimize cytokine release syndrome by reducing Cmax in systemic circulation |
2021-11-01 |
10.1136/jitc-2021-sitc2021.867 |
Kwant Kathryn, Rocha Sony, Stephenson Katrina, Dayao Maria, Thothathri Subramanian, Banzon Rose, Aaron Wade, Hemmati Golzar, Callihan Evan, Yu Timothy, O’Rear Jessica, Bragg Eric, Kwong Willis, Situ Hubert, Hundal Avneel, Yu Stephen, Jackson Taggra, Wright Kevin, Xiao Yinghua, To Linh, Austin Richard, Lemon Bryan, Wesche Holger, Jack Lin S |
764642 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
866 RBN-2397, a novel, potent, and selective PARP7 inhibitor, induces tumor-intrinsic type I interferon responses and adaptive immunity in preclinical models and patient tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.866 |
Kuplast-Barr Kristy, Kuplast-Barr Kristy, Johnson Melissa, Patel Manish, Yap Timothy, Falchook Gerald, LoRusso Patricia, Abo Ryan, Liu Chang, Manyak Erika, Cleary Lisa, Bozon Viviana, Parasuraman Sudha, Keilhack Heike, McEachern Kristen |
764641 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
865 iosH2 exerts potent anti-tumor activity by blocking LILRB1/2 and KIR3DL1 receptor signaling |
2021-11-01 |
10.1136/jitc-2021-sitc2021.865 |
Belaunzaran Osiris Marroquin, Rafiei Anahita, Kumar Anil, Gualandi Marco, Westphal Magdalena, Vogt Lorenz, Smith Sean, Curran Michael, Renner Christoph |
764640 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
860 The anti-tumor activity of HSP-90 therapeutic cancer vaccine (AST-021p) combine with TLR2/3 agonist in a MMTV-neu transgenic model |
2021-11-01 |
10.1136/jitc-2021-sitc2021.860 |
Kang Jinho, Joung Eunkyo, Shin Hunwoo, Ahn Byung cheol, Jung Eunjung, Jung Hun, Park Kyong Hwa |
764639 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
859 Tuning the tumor microenvironment by reprogramming TREM1+ myeloid cells to unleash anti-tumor immunity in solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.859 |
Jahchan Nadine, Ramoth Hanna, Juric Vladi, Mayes Erin, Mankikar Shilpa, Mehta Ranna, Binnewies Mikhail, Dash Subhadra, Palmer Rachael, Pollack Joshua, Rudolph Joshua, Canaday Pamela, Haeggblom Linnea, Santamaria Carlos, Du xiaoyan, Reyno Leonard, Baker Kevin, Liang Linda |